Search details
1.
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.
Nat Immunol
; 24(6): 966-978, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37248417
2.
Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
J Virol
; 96(16): e0058822, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-35916523
3.
Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19.
Int J Mol Sci
; 24(3)2023 Jan 28.
Article
in English
| MEDLINE | ID: mdl-36768847
4.
Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
PLoS Pathog
; 16(9): e1008744, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32898182
5.
The genetic landscape of COVID-19: A South Asian perspective.
J Pak Med Assoc
; 70(Suppl 3)(5): S38-S43, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32515376
6.
Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.
J Infect Dis
; 207(9): 1379-88, 2013 May 01.
Article
in English
| MEDLINE | ID: mdl-23335804
7.
Strengthening research capacity of early-mid career researchers: Implementation and evaluation of the Excellence in Non-COmmunicable disease REsearch (ENCORE) program.
J Investig Med
; : 10815589241236156, 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38378444
8.
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy.
EBioMedicine
; 102: 105054, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38518655
9.
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.
J Virol
; 86(2): 1181-92, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22072755
10.
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
EBioMedicine
; 87: 104391, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36502576
11.
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations.
JCI Insight
; 8(7)2023 04 10.
Article
in English
| MEDLINE | ID: mdl-37036008
12.
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
EBioMedicine
; 98: 104878, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38016322
13.
HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection.
J Med Virol
; 84(7): 993-1001, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22585714
14.
Blood transcriptome responses in patients correlate with severity of COVID-19 disease.
Front Immunol
; 13: 1043219, 2022.
Article
in English
| MEDLINE | ID: mdl-36741372
15.
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.
Nat Commun
; 13(1): 2774, 2022 05 19.
Article
in English
| MEDLINE | ID: mdl-35589689
16.
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.
Cell Rep Med
; 2(3): 100208, 2021 03 16.
Article
in English
| MEDLINE | ID: mdl-33564749
17.
Challenges and opportunities for hepatitis B cure in the setting of HIV--hepatitis B virus co-infection.
Curr Opin HIV AIDS
; 15(3): 193-199, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32141889
18.
Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
J Acquir Immune Defic Syndr
; 84(5): 527-533, 2020 08 15.
Article
in English
| MEDLINE | ID: mdl-32692112
19.
A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.
AIDS
; 33(7): 1105-1115, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31045941
20.
Cell-based influenza vaccines: progress to date.
Drugs
; 68(11): 1483-91, 2008.
Article
in English
| MEDLINE | ID: mdl-18627206